The Oncology Institute, Inc. (TOI) Misses Q2 EPS by 6c

The Oncology Institute, Inc. (NASDAQ: TOI) reported Q2 EPS of ($0.15), $0.06 worse than the analyst estimate of ($0.09). Revenue for the quarter came in at $119.8 million versus the consensus estimate of $112.56 million.

For earnings history and earnings-related data on The Oncology Institute, Inc. (TOI) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• Lantern Pharma (LTRN) files for 2.24M share offering by selling stockholders
• XORTX to voluntarily delist from TSX Venture Exchange